CARDIA INNOVATION AB
Cardia Innovation AB is a biotechnology company that Manufacturs CarbonAid and CarbonMini, CO2 diffusers.
CARDIA INNOVATION AB
Industry:
Biotechnology
Website Url:
http://www.cardiainnovation.com
Status:
Active
Technology used in webpage:
Smelink
Current Employees Featured
Official Site Inspections
http://www.cardiainnovation.com
- Host name: 138.68.100.204
- IP address: 138.68.100.204
- Location: Frankfurt am Main Germany
- Latitude: 50.1188
- Longitude: 8.6843
- Timezone: Europe/Berlin
- Postal: 60313
More informations about "Cardia Innovation AB"
Cardia Innovation AB - Crunchbase Company Profile & Funding
Cardia Innovation AB is a biotechnology company that Manufacturs CarbonAid and CarbonMini, CO2 diffusers.See details»
Cardia Innovation AB - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cardia Innovation AB of Kungens Kurva, Stockholm. Get the latest business insights from Dun & โฆSee details»
Cardia Innovation AB - LinkedIn
Cardia Innovation AB | 51 followers on LinkedIn. Manufacturer of CarbonAid and CarbonMini, CO2 diffusers | Cardia Innovation AB is a biotechnology company based out of Stockholm, Stockholm County ...See details»
Cardia Innovation AB Overview | SignalHire Company Profile
Organization Website: cardiainnovation.com : Cardia Innovation AB industries Biotech: Headquarters Location: Stockholm, Stockholm County, 11156 SE Stockholm, Stockholm โฆSee details»
CarbonAid - Cardia Innovation
CarbonAid® CO 2 diffuser is a disposable device intended for the insufflation of CO 2 into the open cardiothoracic wound cavity to reduce the risk of air embolism during open heart surgery. โฆSee details»
CardiAI 2025 Company Profile: Valuation, Funding & Investors
Information on valuation, funding, cap tables, investors, and executives for CardiAI. Use the PitchBook Platform to explore the full profile.See details»
CarbonMini - Cardia Innovation
CarbonMini® CO 2 diffuser is a disposable device intended for the insufflation of CO 2 into the cardiothoracic wound to reduce the risk of air embolism. CarbonMini® is designed for wounds with size up to 8 cm in diameter. โฆSee details»
Cardia Innovation AB - Drug pipelines, Patents, Clinical trials
Explore Cardia Innovation AB with its drug pipeline, therapeutic area, technology platform, .See details»
Cardia Innovation AB:Company Profile & Technical โฆ
Discovery Company profile page for Cardia Innovation AB including technical research,competitor monitor,market trends,company profile& stock symbolSee details»
Cardia Innovation AB (Cardia Innovation AB) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ โฆ
ไบ่งฃCardia Innovation AB (Cardia Innovation AB)ๅ ฌๅธ็่ฏ็ฉ็ฎก็บฟ๏ผๆฒป็้ขๅ๏ผๆๆฏๅนณๅฐ๏ผไปฅๅๅฎ็ใSee details»
Cardia Innovation AB:Company Profile & Technical โฆ
Https://www.cardiainnovation.com. Cardia Innovation AB is headquartered in Sweden . Cardia Innovation AB has a total of 46 patents . Login to view all basic info. Data Snapshot. 46. โฆSee details»
Cardiology Innovations
Denosumab for osteoporosis reduced fracture risk by 45% but raised the risk of major adverse cardiovascular events by 36% in dialysis-dependent patients, prompting calls for further research.See details»
Product Information - Cardia Innovation
The CarbonAid ® and the CarbonMini ® CO 2 diffusers are intended for the insufflation of CO 2 into the thoracic cavity during cardiothoracic surgery, to reduce the risk of air embolism. They โฆSee details»
Cardia, Inc. - VentureRadar
"Cardia, Inc. specializes in developing medical devices for the non-surgical closure of Congenital Heart Defects. Their Ultrasept product line facilitates the transvenous closure of conditions โฆSee details»
Meet 20 companies innovating in the cardiovascular space
Sep 23, 2022 Blog written by Jessica Hobbis. Cardiovascular diseases (CVDs) are a group of disorders involving blood vessels and the heart. CVDs are the leading cause of death globally, โฆSee details»
Revolutionary advances in the future of cardiology - Mayo Clinic
Mar 21, 2025 In the last 50 years, vast prevention and treatment strides for cardiovascular disease have brought new possibilities. But cardiovascular disease is still the leading cause of โฆSee details»
Heart disease is the worldโs biggest killer - TechCrunch
Sep 9, 2024 CVD is the preeminent cause of death globally, resulting in 17.9 million deaths each year, according to the World Health Organization (WHO). At the top of the list is ischemic heart โฆSee details»
New $30 Million Venture Capital Fund to Spur Innovation in Heart ...
450 Technology Drive Suite 300 Pittsburgh, PA 15219. 412-624-5500. [email protected]See details»
Innovation: A mindset for change - Heart Rhythm
Innovation is a concept that has been an important part of the medical community for centuries. Improvements in technology and devices and pharmaceutical therapies have long depended โฆSee details»
Kardium Raises $145 Million For Innovative Atrial Fibrillation ...
Jan 25, 2021 Vancouverโs Kardium, developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised USD $115 million in a new financing round led by โฆSee details»